Ladenburg Thalmann Financial Services’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $545K | Buy |
771
+35
| +5% | +$24.7K | ﹤0.01% | 1740 |
|
|
2019
Q3 | $472K | Hold |
736
| – | – | ﹤0.01% | 1817 |
|
|
2019
Q2 | $643K | Sell |
736
-28
| -4% | -$24.5K | ﹤0.01% | 1551 |
|
|
2019
Q1 | $441K | Buy |
764
+156
| +26% | +$90K | ﹤0.01% | 1789 |
|
|
2018
Q4 | $170K | Sell |
608
-5
| -0.8% | -$1.4K | ﹤0.01% | 2350 |
|
|
2018
Q3 | $294K | Buy |
613
+222
| +57% | +$106K | ﹤0.01% | 2015 |
|
|
2018
Q2 | $230K | Hold |
391
| – | – | ﹤0.01% | 2127 |
|
|
2018
Q1 | $230K | Sell |
391
-13
| -3% | -$7.65K | ﹤0.01% | 2127 |
|
|
2017
Q4 | $251K | Buy |
404
+231
| +134% | +$144K | ﹤0.01% | 2049 |
|
|
2017
Q3 | $158K | Buy |
173
+97
| +128% | +$88.6K | ﹤0.01% | 2274 |
|
|
2017
Q2 | $70K | Buy |
76
+6
| +9% | +$5.53K | ﹤0.01% | 2771 |
|
|
2017
Q1 | $67K | Buy |
70
+3
| +4% | +$2.87K | ﹤0.01% | 2680 |
|
|
2016
Q4 | $54K | Sell |
67
-16
| -19% | -$12.9K | ﹤0.01% | 2793 |
|
|
2016
Q3 | $69K | Buy |
83
+19
| +30% | +$15.8K | ﹤0.01% | 2525 |
|
|
2016
Q2 | $54K | Buy |
64
+11
| +21% | +$9.28K | ﹤0.01% | 2620 |
|
|
2016
Q1 | $60K | Buy |
53
+7
| +15% | +$7.93K | ﹤0.01% | 2451 |
|
|
2015
Q4 | $58K | Buy |
46
+3
| +7% | +$3.78K | ﹤0.01% | 2456 |
|
|
2015
Q3 | $59K | Buy |
43
+5
| +13% | +$6.86K | ﹤0.01% | 2363 |
|
|
2015
Q2 | $69K | Buy |
38
+28
| +280% | +$50.8K | ﹤0.01% | 2365 |
|
|
2015
Q1 | $16K | Sell |
10
-149
| -94% | -$238K | ﹤0.01% | 3334 |
|
|
2014
Q4 | $121K | Buy |
+159
| New | +$121K | ﹤0.01% | 1775 |
|